Adage Capital Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Adage Capital Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-200,000	Closed	-$8.64M	–	1047
2020 Q4	$8.64M	Hold	200,000	–	–	0.02%	618
2020 Q3	$8.22M	Sell	200,000 -100,000	-33%	-$5.17M	0.02%	561
2020 Q2	$18M	Sell	300,000 -5,200	-2%	-$476K	0.05%	408
2020 Q1	$23M	Sell	305,200 -68,708	-18%	-$7.91M	0.07%	295
2019 Q4	$51.4M	Buy	373,908 +38,100	+11%	+$4.63M	0.13%	198
2019 Q3	$39.9M	Buy	335,808 +162,728	+94%	+$22.7M	0.1%	236
2019 Q2	$24.2M	Buy	173,080 +65,600	+61%	+$11.5M	0.06%	323
2019 Q1	$19.2M	Hold	107,480	–	–	0.05%	387
2018 Q4	$16.9M	Buy	+107,480	New	+$16M	0.05%	376

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners's ORTX Position: Q1 2021 in Review

Adage Capital Partners sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 200,000 shares — an estimated $8.64M sold.

Adage Capital Partners first reported a position in ORTX in Q4 2018 and held it in 9 quarters. The position peaked at $51.4M in Q4 2019. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

Adage Capital Partners reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Adage Capital Partners sold 200,000 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $8.64M.
Adage Capital Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 9 quarters.
Adage Capital Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $51.4M in Q4 2019.
83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.